(Q33588520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

C Lewis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

293-308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193684%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199957030-00003

4 December 2019

exact match

0 references

cites work

A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix

1 reference

12 December 2020

The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat

1 reference

12 December 2020

Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943).

1 reference

12 December 2020

A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

The role of glutathione in combination with cisplatin in the treatment of ovarian cancer

1 reference

12 December 2020

Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results

1 reference

12 December 2020

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

12 December 2020

The anthracycline antineoplastic drugs

1 reference

12 December 2020

The effect of doxorubicin on hepatic and cardiac glutathione

1 reference

12 December 2020

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.

1 reference

12 December 2020

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

12 December 2020

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

12 December 2020

[Binding of epirubicin to human plasma protein and erythrocytes: interaction with the cytoprotective amifostine]

1 reference

12 December 2020

Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin

1 reference

12 December 2020

Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.

1 reference

12 December 2020

Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.

1 reference

12 December 2020

Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility

1 reference

12 December 2020

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

1 reference

12 December 2020

Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna

1 reference

12 December 2020

A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine

1 reference

12 December 2020

Mesna side effects which imitate vasculitis

1 reference

12 December 2020

Phase I Controlled trials of WR-2721 and cyclophosphamide

1 reference

12 December 2020

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

12 December 2020

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

12 December 2020

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

1 reference

12 December 2020

Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin

1 reference

12 December 2020

A general mechanism for microsomal activation of quinone anticancer agents to free radicals

1 reference

12 December 2020

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

12 December 2020

Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.

1 reference

12 December 2020

Reduction of daunomycin toxicity by razoxane

1 reference

12 December 2020

The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).

1 reference

12 December 2020

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

12 December 2020

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

12 December 2020

Compatibility of amifostine with selected drugs during simulated Y-site administration

1 reference

12 December 2020

Chemoprotectants for cancer chemotherapy.

1 reference

12 December 2020

Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicin

1 reference

12 December 2020

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

1 reference

12 December 2020

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

12 December 2020

Phase I study of ICRF-187 using a daily for 3 days schedule

1 reference

12 December 2020

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

1 reference

12 December 2020

The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats

1 reference

12 December 2020

Stereochemistry of Intercalation: Interaction of Daunomycin with DNA

1 reference

12 December 2020

Mechanism of phospholipid peroxidation induced by ferric ion-ADP-adriamycin-co-ordination complex

1 reference

12 December 2020

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)

1 reference

12 December 2020

A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration.

1 reference

12 December 2020

Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group

1 reference

12 December 2020

Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.

1 reference

12 December 2020

Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy

1 reference

12 December 2020

Protective effects of glutathione on cisplatin neurotoxicity in rats

1 reference

12 December 2020

Amifostine (Ethyol): pharmacokinetic and pharmacodynamic effects in vivo

1 reference

12 December 2020

Clinical overview of mesna

1 reference

12 December 2020

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

1 reference

12 December 2020

WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial

1 reference

12 December 2020

Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancy

1 reference

12 December 2020

Allergic contact dermatitis from mesna

1 reference

12 December 2020

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

1 reference

12 December 2020

Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.

1 reference

12 December 2020

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

1 reference

12 December 2020

Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity

1 reference

12 December 2020

Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial

1 reference

12 December 2020

Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support

1 reference

12 December 2020

A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer

1 reference

12 December 2020

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

1 reference

12 December 2020

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

1 reference

12 December 2020

Cardiotoxicity of adriamycin and related anthracyclines

1 reference

12 December 2020

Oral administration of mesna with ifosfamide.

1 reference

12 December 2020

Amifostine (Ethyol): dosing, administration and patient management guidelines

1 reference

12 December 2020

Phase I trials of WR-2721 and cis-platinum

1 reference

12 December 2020

Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer

1 reference

12 December 2020

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study

1 reference

12 December 2020

Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors

1 reference

12 December 2020

Bioavailability of orally administered mesna

1 reference

12 December 2020

Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Beneficial effects of melanocortins

1 reference

12 December 2020

Reduced glutathione protects against cisplatin-induced neurotoxicity in rats

1 reference

12 December 2020

The cell-specific anti-proliferative effect of reduced glutathione is mediated by gamma-glutamyl transpeptidase-dependent extracellular pro-oxidant reactions.

1 reference

12 December 2020

Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.

1 reference

12 December 2020

Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells

1 reference

12 December 2020

Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders

1 reference

12 December 2020

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

1 reference

12 December 2020

Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits

1 reference

12 December 2020

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial

1 reference

12 December 2020

Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence

1 reference

12 December 2020

Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group

1 reference

12 December 2020